Search research articles
Contact Us
Filters
Showing results (91-100 of 126) with videos related to
Page
of 13
Sort By:
Diabetes, Obesity & Metabolism
|
August 12, 2011
Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
R R Henry, V R Aroda, S Mudaliar, et al.
Diabetes
|
July 1, 1997
PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects
K S Park, T P Ciaraldi, L Abrams-Carter, et al.
Endocrinology
|
August 5, 2000
Protein kinase Ctheta expression is increased upon differentiation of human skeletal muscle cells: dysregulation in type 2 diabetic patients and a possible role for protein kinase Ctheta in insulin-stimulated glycogen synthase activity
C E Chalfant, T P Ciaraldi, J E Watson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1990
Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus
B Gumbiner, K S Polonsky, W F Beltz, et al.
Diabetes, Obesity & Metabolism
|
January 29, 2011
Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes
P K Shah, S Mudaliar, A R Chang, et al.
The Journal of Clinical Investigation
|
September 1, 1996
Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms
R R Henry, T P Ciaraldi, L Abrams-Carter, et al.
Diabetes Care
|
September 10, 1999
Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects
S R Mudaliar, F A Lindberg, M Joyce, et al.
Diabetes
|
June 1, 1997
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia
S E Nikoulina, T P Ciaraldi, L Abrams-Carter, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2015
Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
S E Inzucchi, M A Nauck, U Hehnke, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects
K S Park, T P Ciaraldi, L Abrams-Carter, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 126) with videos related to
Sort By:
Page
of 13
Diabetes, Obesity & Metabolism
|
August 12, 2011
Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
R R Henry, V R Aroda, S Mudaliar, et al.
Diabetes
|
July 1, 1997
PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects
K S Park, T P Ciaraldi, L Abrams-Carter, et al.
Endocrinology
|
August 5, 2000
Protein kinase Ctheta expression is increased upon differentiation of human skeletal muscle cells: dysregulation in type 2 diabetic patients and a possible role for protein kinase Ctheta in insulin-stimulated glycogen synthase activity
C E Chalfant, T P Ciaraldi, J E Watson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1990
Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus
B Gumbiner, K S Polonsky, W F Beltz, et al.
Diabetes, Obesity & Metabolism
|
January 29, 2011
Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes
P K Shah, S Mudaliar, A R Chang, et al.
The Journal of Clinical Investigation
|
September 1, 1996
Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms
R R Henry, T P Ciaraldi, L Abrams-Carter, et al.
Diabetes Care
|
September 10, 1999
Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects
S R Mudaliar, F A Lindberg, M Joyce, et al.
Diabetes
|
June 1, 1997
Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia
S E Nikoulina, T P Ciaraldi, L Abrams-Carter, et al.
Diabetes, Obesity & Metabolism
|
May 15, 2015
Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes
S E Inzucchi, M A Nauck, U Hehnke, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 20, 1998
Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects
K S Park, T P Ciaraldi, L Abrams-Carter, et al.
Page
of 13